Summit on Controlled Substances – Regulation, Litigation, and Enforcement

Lynn Mehler served as both co-chair and speaker at the American Conference Institute's (ACI) Summit on Controlled Substances – Regulation, Litigation, and Enforcement.

Single, Shared System Risk Evaluation and Mitigation Strategies: Opportunities and Challenges

Lynn Mehler was a speaker during a Food and Drug Law Institute (FDLI) live webinar on 14 May.

Understanding DEA Regulations and FDA Interactions: A Case Study on Opioids

Lynn Mehler was a panel member during a session at the Food and Drug Law Institute (FDLI) Annual Conference: Exploring Advanced Topics in Food and Drug Law.

DEA regulatory compliance for educational institutions

Join Jason Hadges and Lynn Mehler, partners in our Health Regulatory practice, for a complimentary webinar on federal controlled substances regulatory compliance considerations for...

Current issues in the distribution of controlled substances

Join us for a complimentary webinar on current issues affecting the distribution of controlled substances. In an efficient hour, we will provide an overview of the current state of play in...

Loading data